EARNINGS AND TRADING: Optima says full-year revenue up as expected
The following is a round-up of earnings and trading updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:
----------
Optima Health PLC - occupational health services provider - Issues a trading update for the financial year ended March 31, reporting revenue of approximately £121 million. This would be up 15% from £105 million the year before, which Optima says is in line with market expectations. Notes that other income of £4.7 million was recognised relating to a previously disclosed procurement matter. Reiterates that it expects adjusted earnings before interest, tax, depreciation and amortisation to be about 10% higher than previous market guidance. Reports a net debt position of £94.4 million as of March 31, with a £21.6 million cash balance and £116 million of debt, but says net debt has reduced as of the end of May following repayment of a £30 million shareholder bridging loan for its March acquisition of PAM, which as of June 1 has delivered £1.3 million of annualised cost synergies. Says it continues to make strong progress against its strategic objectives and medium?term targets of £200 million in annual revenue and £40 million of adjusted Ebitda. Expects to report full-year results in August.
----------
Accsys Technologies PLC - London-based wood building products manufacturer - Reports group revenue of €153 million for the year ended March 31, up 12% or 20% like-for-like, from €137 million the year before. Underlying Ebitda rises 26% to €21.1 million from €16.8 million, while adjusted Ebitda rises 96% to €21.2 million from €10.8 million. Pretax loss narrows to €570,000 from €20.8 million. Says its LFL revenue growth was driven by a solid trading performance across all regions, continued pricing discipline, and a favourable sales mix with a higher year-on-year proportion of Accoya Color sales. Accoya sales volumes increases 21%, while revenue from its Accoya USA joint venture more than doubles to €30.3 million from €10.9 million. The JV also swings to Ebitda profitability of €90,000 from an €6.0 million loss, partially driving the group adjusted Ebitda surge. Accsys says trading is in line with expectations for financial 2027, and that it is on track to achieve the phase 1 targets of its ’FOCUS’ strategy. ‘While macroeconomic conditions remain uncertain with some inflationary pressures arising from the conflict in the Middle East, we are well positioned to manage the potential impact through product differentiation, geographical diversification, and pricing discipline,’ Accsys says.
----------
US Solar Fund PLC - investor in utility-scale solar power plants across North America - Says net asset value for its first quarter ended March 31 ‘remained stable’ at 62 US cents per share, up by around 2.0% quarter-on-quarter. Says portfolio generation for the period was 8.8% below its forecast, compared with previous long-term forecasts, and underperforms by 0.9% against its revised forecasts for 2026. Attributes the underperformance against long-term forecasts to ‘technical (non-weather) factors’, partially offset by favourable weather conditions. Expects a lower first-half performance to be offset by higher performance in the second, once work on its Chiloquin asset is completed. ‘As such performance when compared to the revised forecasts for 2026 has largely been in line with expectations,’ the company says. Also notes an ‘improved performance’ from its two Californian assets, and says overall performance continued to be impacted by lead times and utility grid outages, ‘although to a lesser extent than the prior 12-month period’. USF says the potential sale announced on May 18 of its solar generation assets, having granted the prospective buyer a 90-day exclusivity period, remains subject to due diligence and legal documentation discussions.
----------
Copyright 2026 Alliance News Ltd. All Rights Reserved.